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6. Abstrak: 
Pengenalan 
Penyakit Hirschsprung ialah penyakit masalah perkembangan saraf saluran pemakanan 
yang menyebabkan pengembangan usus besar yang melampau and menyebabkan 
masalah usus tersumbat pada masa neonat. Hospital USM adalah satu-satunya unit 
surgeri pediatrik di utara pantai timur M\laysia sehingga hujung tahun 2005. Semua 
rujukan kes berhubung dengan penyakit 'Hirschsprung' telah dirawat di sini. Secara 
amnya perawatan bermula dengan pencucian rektum sehingga diagnosa yang pasti 
telah didapati melalui biopsi rektum. Selepas itu pembedahan untuk membuat 
kolostomi akan dilakukan. Pada umur bayi lebih kurang setahun atau berat badan 
mencapai 10 kilogram, pembedahan definitif akan dijalankan. Sebelum tahun 2004 
pembedahan yang selalunya dijalankan di Hospital USM ialah prosedur Duhamel. 
Selepas pembedahan ini pesakit akan menjalani satu lagi pembedahan untuk menutup 
kolostomi mereka. 
Objektif: 
Kajian ini adalah bertujuan untuk mendapatkan data mengenai penyakit ini dalam 
konteks demografik, simptom awalan dan umur pesakit yang menunjukkan simptom 
penyakit 'Hirschsprung' dan waktu diagnosa. Data mengenai cara diagnosa, cara 
perawatan, kesan jangka panjang dan masalh masalah mendiagnosis pesakit pesakit 
juga dikaji. 
Metodologi : 
Kajian ini adalah retrospektif yang merangkumi semua pesakit yang didiagnosakan 
mempunyai penyakit ini dan menjalani pembedahan definitif mereka di hospital ini. 
Tarikh kajian ini adalah dari Februari 1999 sehingga Februari 2004; merangkumi 5 
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tahun kajian. Pesakit yang tidak menenma nasihat pembedahan definitif tidak 
dimasukkan ke dalam kajian ini. 
Keputusan: 
Terdapat 94 pesakit yang dapat dikaji untuk kajian ini. Nisbah lelaki kepada 
perempuan ialah 4:1. Umur pesakit menunjukkan simptom simptom penyakit ini 
adalah 2 hari sehingga 13 tahun. Tujuh puluh tiga peratus (73.4%) pesakit datang ke 
hospital dalam umur kurang dari 3 bulan. Simptom simptom adalah seperti berikut; 
kembung perut (87.2%), muntah (61.7%), tidak mahu menyusu (55.3%), tidak 
membuang mekonium sejak lahir (47.9%) dan sembelit (46.8%). Tujuh belas peratus 
(17%) daripada pesakit mempunyai kecacatan lain dan 3.2% mempunyai adik beradik 
yang mempunyai penyakit yang sama. Enam puluh tiga peratus (63.4%) didiagnosakan 
menggunakan biopsi rektum secara sedutan. Sembilan puluh lima peratus (95. 7%) 
daripada pesakit menjalani pembedahan Duhamel untuk rawatan definitif, 3 
'transanal pull-through' dan 1 prosedur Soave. Terdapat satu kematian dan 1a 
disebabkan oleh jangkitan enterokolitis. Pesakit ini juga menghidapi sindrom Down 
dan penyakit kongenital jantung berlubang. 
Dalam rawatan susulan 74% tidak mempunyai masalah besar seperti sembelit, 
enterokolitis, hilang kawalan untuk membuang au besar dan keperluan untuk 
pembedahan tambahan. Terdapat 10.6% daripada pesakit yang memerlukan 
pembedahan tambahan. Lima orang pesakit telah menjalani pembedahan definitif 
semula. 
Kesimpulan: 
Data demografik pesakit adalah hampir serupa dengan yang telah dikaji di tempat 
tempat lain. Simptom awalan yang membawa kepada diagnosa juga hampir sama 
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dengan kajian kajian lain. Pembedahan yang dijalankan di Hospital USM adalah 
majoritinya prosedur Duhamel pada masa kajian dijalankan dan sedang menuju ke arab 
satu fasa pembedahan sahaja pada masa kini. Pembedahan yang dilakukan adalah 
selamat dan tiada komplikasi yang membahayakan pesakit. 
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7. Abstract: 
Introduction 
Hirschsprung' s disease is a developmental disorder of the enteric nervous system 
causing congenital megacolon and the commonest cause of intestinal obstruction in the 
neonatal period. Being the only Pediatric surgical unit until the end of 2005 Hospital 
USM undertook all the references for Hirschsprung's disease in the upper east coast 
region of Malaysia. The treatment of the disease started when a patient is suspected of 
having the disease clinically. The patient would receive rectal irrigation until the 
diagnosis is confirmed by rectal biopsy. When the diagnosis is confirmed the child 
would have a colostomy created. When the child reached about one year old or weight 
of 10 kilograms, the definitive procedure would be done. Until 2004, the procedure of 
choice in the hospital was Duhamel procedure. After the definitive procedure, the 
colostomy would be closed. 
Objective: 
The objective of the study is to review the children presenting with Hirschsprung's 
disease to the hospital and described the demographics, mode and age of presentations, 
diagnosis, operative treatment, complications and outcome of the patients. 
Methodology: 
The study was retrospective review study of the patients who were diagnosed and had 
their definitive pull-through procedure in the hospital during a period of 5 years (from 
February 1999 - February 2004). Patients who defaulted prior to the definitive 
procedure were excluded. 
XX 
Results: 
There were 94 patients whose data was available for the review. There were 4: 1 male 
to female ratio with age of presentation ranging from I day old and I3 years old with 
73.4% presented within the age of 3 months. The most common of clinical presentation 
was abdominal distension (87.2%) followed by vomiting (61.7%), poor feeding 
(55.3%), delayed passage of meconium (47.9%) and chronic constipation (46.8%). 
Seventeen percent (I 7%) of patients had other associated anomalies and 3.2% had a 
family history. Sixty three percent (63.4%) were diagnosed with rectal suction biopsy. 
Ninety five percent (95.7%) of patients had Duhamel type of pull-through procedure 
with 3 had transanal pull-through and only one who had Soave. There was a mortality 
recorded for the study and it was attributed to enterocolitis. The patient was also 
having Down syndrome and congenital heart disease. 
In the follow up period an average of 74% were free of complications of constipation, 
enterocolitis, incontinent, redo operation. There was I 0.6% reoperation rate. Five 
patients needed a complete redo of their definitive procedures. 
Conclusion 
The demographics finding of the study is quite similar to the patterns in the other parts 
of the world. The presenting symptoms were also quite similar to other studies. The 
definitive procedure of choice during the study time was Duhamel operation. The 
operative outcome was safe and acceptable. 
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1. INTRODUCTION 
Hirschsprung's disease is a developmental disorder of the enteric nervous system 
(ENS) characterized by absence of ganglion cells in the myenteric and submucosal 
plexuses along a variable portion of the distal intestine. It is the most common cause of 
bowel obstruction in the neonatal period. 1 
In the 1691 Frederick Ruysch described a 5-year old child who might have 
Hirschsprung's disease who died of intestinal obstruction and constipation. In 1800 
Domenico Battini' s account of a child with congenital megacolon was published after 
his death 1• In 1887, Hirschsprung, in his original report, described 2 patients, aged 9 
and 11 months, with megacolon. Both died, and at postmortem examination he 
described severe inflammation and ulcer formation in the colon2• 
Tittel in 190 1 was the one who first noted the absence of ganglion cells in the distal 
colon of a 15-month old child with Hirschsprung's disease1• Then it was established 
that abnormalities of innervation within the colon and the absence of ganglion cells is 
pathognomonic of Hirschsprung' s disease. 
Ehrenpreis noted in 1946 that the proximal colon was dilated and hypertrophied due to 
distal obstruction 1• Whitehouse and Kemohan presented summary of the literature and 
a series of their own patients that documented aganglionosis within the distal colon or 
rectum was the cause of the functional obstruction 1• In 1949, Swenson et al published 
the discovery of the cause of the disease was based on a series of clinical observations 
indicating that there was a defective segment of distal colon producing a partial bowel 
obstruction. Peristaltic tracings of the dilated proximal colon recorded progressive 
1 
contractions3• However, this peristaltic wave did not enter the more distal narrow 
segment. This was suggestive evidence of a physiologic defect in that distal segment. 
Therefore, an operative technique was devised. In 1949, Swenson and colleagues 
published an article recommending rectosigmoidectomy with preservation of the 
sphincters as the optimal treatment of this disease3• The procedure was called Swenson 
pull-through. However, this initial procedure caused a lot of enterocolitis episodes 
which led to modifications of the procedure. 
In 1956 Bernard Duhamel proposed a retro-rectal and trans-anal pull-through 
operation for the treatment of Hirschsprung's disease 4• The procedure, originally 
intended to be palliative, rapidly became a radical method. As experience was gained, 
certain problems appeared which induced several authors to design improvements and 
modifications of the details of the original technique 4• 
The Soave procedure (or endorectal pullthrough) was first performed in the 1960 by 
Franco Soave. 3 This operation was designed to avoid injury to pelvic vessels and 
nerves and protect the internal sphincter, all of which are theoretically at risk during 
the Swenson and Duhamel procedures. The operation consists of a mucosal 
proctectomy with preservation of the rectal muscular cuff, and the normally innervated 
colon is pulled through the muscular cuff and anastomosed just above the dentate line. 
In the original description the pulled-through bowel was left hanging out for several 
weeks and relied on scarification of the 2 segments of intestine to support the 
anastomosis. Boley's modification of the Soave procedure in 1964 , in which the 
anastomosis is performed primarily, is employed by most surgeons today. 3 Other 
approaches that are used more frequently outside of North America include the 
2 
Rehbein procedure and the use of long myectomy without resection. The Rehbien 
operation involves a somewhat higher anastomosis than the previously mentioned 
operations, although long-term follow-up suggests very good results in experienced 
hands4• 
Recently, the multi-stage approaches have been challenged. The use of a primary 
endorectal pull-through (ERPT) in the management of neonates with Hirschsprung's 
disease represents a significant change from the classic approach to its treatment. The 
first successful report of a primary pull-through for Hirschsprung's disease came from 
So et al in 1980. 5 Subsequently, due to the simplified nature of this approach and the 
potential for cost savings, several groups have reported on the use of this procedure 
and its safety, therefore improving morbidity and mortality rates in infants with 
Hirschsprung's disease. 
This study documented the number of patients treated in Hospital USM for the period 
of 5 years from February 1999 to February 2004. Until late 2005, Hospital USM was 
the only Pediatric Surgical Unit in the East Coast of Malaysia. 
3 
2. LITERATURE REVIEW 
2.1 Epidemiology 
Hirschsprung's disease occurs in about 1 in 5000 live births (1/5257 US, 1/3070 
Oman, 1/7165 Australia and 1:4697 in Japan). 3• 6-8 The male to female sex ratio is 4:1. 
The ratio however, dropped to 1: 1 in total colonic aganglionosis. There is no 
association between race, geographical area and incidence of aganglionosis. 
Approximately 10% of children with Hirschsprung's have positive family history, 
especially those with longer segment disease.9 
2.2.Pathology 
Grossly the features of Hirschsprung' s disease depend on the time of it being 
diagnosed with transition zone features being more obvious. Classically the appearance 
of the bowel was contracted ganglionic segment, funnel shaped transition zone and 
dilated proximal normal colon. 
The absence of ganglion cells in a variable length of distal bowel commencing from 
the rectum upwards thus results in a normal caliber rectum with dilatation of the 
normally innervated proximal colon. The absence of the ganglions is thus the essential 
cause of Hirschsprung's disease. As the ganglia are part of the enteric nervous system 
that coordinate the motility of the bowel, their absence made the bowel become 
dysmotile, aperistaltic and causes the symptoms classical to the disease. 
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2.2.1. Etiology 
The most widely accepted etio-pathogenic hypothesis is based on a defect of 
craniocaudal migration of neuroblasts originating from the neural crest (NC), that 
under normal circumstances reach the small intestine in the 7th week of gestation and 
the rectum in the 12th week. 11 The earlier the migration arrest, the longer the distal 
aganglionic intestinal portion. 
The neural crest is one of the earliest organs to form within the developing embryo. 
The cells contribute to a vast amount of structures throughout the body. They follow 
migratory pathways that are dependent on their axial level of origin. Once they reach 
their final destination, neuroblasts differentiate into numerous cell types which include 
adrenal medulla, neurons and glia of the sympathetic and parasympathetic nervous 
system, melanocytes and neuroendocrine cells 10• 
In 1974 Bolande suggested neurocristopathies for the conditions arising from neural 
crest derived tissues, and divided them into simple and complex. Hirschsprung's 
disease was classified as a simple neuroscristopathy because it is characterized by a 
single pathological process, of unifocal and localized condition 11 • 
The ganglion cells of the ENS (enteric nervous system) thus originate from the neural 
crest. These cells migrate first into the Auerbach's (myenteric) plexus and then into 
Meissner's (submucosal) plexus in a cranio-caudal fashion as mentioned before. 
The vagal neural crest generally is considered to be the source of both neurons and 
supportive cells of the ENS along the digestive tract. The vagal neural crest also 
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originates cardiac ganglia and is involved in the development of cardiac outflow tract, 
thymic stromal cells and the parathyroids 11 • 
Using ablation techniques Peters-Vander Sanden et al, studied regional differences 
within the vagal neural crest with regard to the formation of the ENS. 11 They were 
able to show that ablation of the total vagal neural crest resulted in total aganglionosis 
from anus through midgut, the foregut (esophagus, stomach and duodenum) being 
normally ganglionic. Ablation of the vagal crest adjacent to somites 3 to 5 resulted in 
aganglionosis of the hindgut only. Ablations of the vagal neural crest not including this 
segment had no effect on the formation of the ENS 11 • 
In any case to be able to contribute to ENS development, NC cells have to leave the 
neural tube, migrate to the gut, enter it at some point and start their crania-caudal 
migration along the hind gut. These events are regulated by molecular and cellular 
mechanisms that are not completely understood 12• 
The other theory is that neural crest cells arrived at their destination but then failed to 
survive, proliferate or differentiate due to abnormalities within their 
microenvironment13• Fibronectin and laminin are glycoproteins that facilitate neural 
cell migration and development. Gaillard et al have shown that there is abnormal 
distribution of these proteins in the bowel of patients with Hirschsprung's disease 
which may prevent the migrations of ganglion cells into the extracellular matrix. 11 
Langer et al showed abnormal cell to cell interactions between aganglionic smooth 
muscle and ganglion cells. 14 
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Other studies have shown differential expression of the neural cell adhesion molecule 
(NCAM) in aganglionic compared with normal bowel. 11 The absence of neurotrophic 
factors such as neutrophen was also noted in patients with Hirschsprung's disease. 15 
These support the concept that the microenvironment may also play a role in producing 
the distal aganglionosis that is characteristic of Hirschsprung' s disease. 
2.2.2. The major gene for Hirschsprung's disease 
Approximately 10% of children with Hirschsprung' s disease have positive family 
history, especially those with longer segment disease. Males are 4 times more likely to 
be affected than females 16• Siblings of female index patients have a 360 fold increased 
risk and siblings of male patients have a 130 fold risk of developing Hirschsprung's 
disease 1• Children with Down syndrome and other genetic, abnormalities also have a 
higher incidence of Hirschsprung' s disease and the incidence of associated congenital 
anomalies is approximately 20%1• 
The first step toward understanding of the molecular basis of Hirschsprung' s disease as 
well as the nature of its genetic transmission was the observation of a young female 
patient with total colonic aganglionosis carrying a de novo interstitial deletion of 
chromosome 1 0 ( 46xx, dell Oq 11.21-q21.2). 11 Human-hamster somatic cell hybrids 
retaining the deleted (Hy185-0) and the non-deleted (Hy179-Q) chromosome 10 were 
produced from lymphocytes of the total colonic aganglionosis patient using an 
immunomagnetic positive selection method . The availability of these 2 somatic cell 
hybrids allowed the mapping of a series of chromosome I 0-specific polymorphic 
markers, either inside or outside the deletion 11 • 
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Two studies, I using a cohort of I5 families with Hirschsprung's disease and the other 
done by analyzing Hirschsprung's disease pedigree, confirmed that the genetic 
abnormality was in the proximal portion of chromosome I 011 • 
The refinement of the genetic and physical maps of the proximal portion of the long 
arm of chromosome 1 0 found genes for multiple endocrine neoplasia type 2A and 2B 
(MEN 2A, MEN2B) as well as the gene responsible for familial medullary thyroid 
cancer (FMTC). Two additional interstitial deletions of chromosome I Oq associated 
with Hirschsprung's disease were observed. The characterization of the smallest region 
of overlap (SRO) among the 3 deleted chromosomes 10 allowed narrowing the 
candidate Hirschsprung's disease region to an interval of less than 250kb 11 • The RET 
proto-oncegene was the only cloned gene known to be located in this interval 1• 
RET proto-oncegene encodes a transmembrane receptor tyrosine kinase on 1 Oq 11.2 
and encodes 20 exons. Receptor tyrosine kinases are essential for normal growth and 
differentiation of cell lines. RET knocked out mice show few neural crest cells, which 
do not migrate beyond the esophagus, defects in sympathetic innervations, as well as 
the absence of renal development11 • Mutations in the RET proto-oncogene have been 
found in 17-38% of children with short segment Hirschsprungs disease, and 70-80% of 
those with long segment involvement. Missence and nonsense mutations and a few 
base-pair deletions or insertions of the RET proto-once gene have been identified since 
then in Hirschsprungs disease patients by different groups. 11 
Other genetic alterations may also be the cause Hirschsprungs disease, as only 50o/o of 
familial and 20% of sporadic cases showed RET proto-once gene mutations. 
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RET polymorphism may also predispose to the isolated or sporadic from of 
Hirschsprungs disease. Strong association between specific alleles of the RET proto-
oncegene and Hirschsprung's disease has been noted, specifically cl35g/A and 
c2307G that may potentially cause Hirschsprung's disease in the recessive or in dose 
dependent manner.I 8 Patients with MEN 2B often developed ganglioneuromatosis of 
the gastrointestinal tract, which can be associated with distension, megacolon and loss 
of tone despite histological normal ganglion cells 19• 
A possible explanation for coexistence of MEN 2 and Hirschsprung's disease could be 
activation of apoptosis in the enteric ganglion cells in response to an inappropriate 
mitogenic signal transduced by the gain of function mutation of the RET proto-
oncegene 1• 
Glial cell line derived neurotrophic factor (GDNF) is the first RET receptor ligand 
identified GDNF is proposed to act as a ligand for a multisubunit receptor in which the 
glycosylphosphatidylinositol-linked protein (GDNF R-a) provides the ligand binding, 
and RET provides the signalling component. Functional assays have shown that, in the 
absence of either GDNF or GDNFR -a, RET signaling is reduced or absent II. Because 
RET mutation did not account for all the Hirschsprungs disease cases studied, GDNF 
appeared to be an ideal candidate for mutation analysis studies. Martucciello et al in 
the Gaslini Children's Hospital confirmed the infrequency of GDNF mutations in 
association with Hirschsprungs disease. That is, 4.6% of all Hirschsprung's disease 
cases studied agreed with mutation rates reported by other investigators which ranged 
from 0.9% to 5.5%.II GDNF immunoreactivity was localized in the ganglia of 
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myenteric and submucous plexuses. In the normal colon and in the ganglionic segment 
of Hirschsprungs disease, a strong granular red staining was obtained in the satellite 
elements and the cellular membranes of the ganglion cells GDNF immunoreactivity 
was absent in the aganglionic segment of Hirschsprung' s disease 11 • 
GDNF expression deficit in the distal aganglionic segment could be an important 
cofactor in Hirschsprungs disease pathogenesis. Absence of GDNF in the distal 
hindgut could determine a missed activation and phosphorylation of the RET receptor 
in the absence of RET proto-oncogence mutations causing enteric neuroblast migration 
d H. h ' d" II arrest an usc sprung s tsease . 
In addition to GDNF, RET has at least 3 other ligands that are members of the GDNF 
family, Neurturin (NTN), persephin (PSP) and artemin (ART). Neurturin has also been 
found to be important for development in a subset of parasympathetic and enteric 
neurons. 20 Mice that lack NTN have defect in the cholinergic innervations of the 
colon11 • 
Waardenburg-Shah (WS4) syndrome combined features of Waardenburg and long 
segment Hirschsprung' s Disease. There are 3 known gene mutations that cause WS4 
including the Endothelin-B receptor (EDNRB), the gene for the ligand endothelin-3 
(EDN-3) and soxl01• These genes are involved in the signalling and control of the 
normal development of neural crest stem cells, which differentiate into both 
melanocytes and enteric ganglia. Sox I 0 is a member of the Sox gene family related to 
HMG box region of the testis determining gene SRY. Analysis of the mutation appears 
to show a correlation between the specific location of the mutation in the sox 10 
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sequence and the severity of intestinal aganglionosis. Mutations closer to the HMG 
portion of the gene lead to short-segment Hirschsprung's disease whereas mutations 
that affect the C-terminal transactivation domain lead to long segment or total colonic 
Hirschsprung' s disease 22• 
ZFHX I b gene is located in the deleted segment of chromosome 2q22 and encodes for 
the transcription factor SMAD interacting protein 1 (SIP1). SIP1 is a signal transducer 
involved in the transforming growth factor J3 (TGF~) signaling pathway. Interruption 
of SMAD signalling pathway caused a syndrome that includes mental retardation, 
microcephaly, distinct facial features and Hirschsprung's disease. This showed SIP1 
importance in normal neural crest cell development11 • 
PHOX2B is also implicated in Hirschsprung's disease whereby it may play a 
regulatory role in RET expression and account for the lack of enteric nervous system 
development in Hirschsprung' s disease23• 
2.3. Pathophysiology of Hirschprung's Disease. 
The normal motility in the gastro intestinal tract depends on the enteric nervous 
system, the smooth muscle layers and the interstitial cells of Cajal (ICCs). Neural crest 
cells populate submucosal and myenteric plexuses. The neurons within these plexuses 
comprise of the enteric nervous system which control the gut mobility, secretion, 
absorption and blood flow. These neurones are responsible for coordination of the 
intestinal smooth muscle. The absence of ganglia in the subumucosal and myenteric 
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plexuses results in the abnormal bowel motility that ts pathognomonic of 
Hirschsprung' s disease. 
The smooth muscle is in a state of relaxation under normal physiologic condition. 
Intrinsic nervous system, to which the ganglion cells belong, is unique to the intestine. 
These nerves are inhibitory and utilize peptidergic neurotransmitters such as vasoactive 
inhibitory peptide (VIP) and substance P. 
They act on smooth muscle through the release of nitric oxide which is synthesized by 
the activation of neuronal NO (nitric oxide) synthases. The absence of ganglion cells is 
associated with a twofold increase in the innervation of the aganglionic intestine by 
extrinsic adrenergic and cholinergic fibers. 
Extrinsic cholinergic fibers mediate signal for muscular contraction using acetylcholine 
as the main neurotransmitter. Cholinergic innervation is markedly increased within the 
aganglionic segment, and since it is predominantly excitatory the aganglionic bowel is 
chronically contracted. This functional obstruction leads to the clinical presentation 
characteristic of Hirschsprung' s disease 11 • 
The interstitial cells of Cajal (ICCs) are pacemaker cells found within the smooth 
muscle of the intestine, that generate physiological slow waves in the gastrointestinal 
tract and have an important role in the control of gut motility. These cells mediate 
between the enteric nerves and smooth muscle cells of the gut. Deficiency of ICC has 
been found within aganglionic bowel. 
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2.4. Clinical Presentation 
About 50% to 90% of children present during the neonatal period. The common 
presenting features in the neonatal period were abdominal distension, feeding 
intolerance with bilious aspirates or bilious vomiting and delayed passage of 
meconium. 
Delayed passage of meconium is defined as failure to pass meconium in the first 48 
hours of life. Normally, 95% of normal term infants pass meconium in the first 24 
hours of life and less than 10% of children with Hirschsprung's disease passed 
meconium during the time. 
Due to functional distal bowel obstruction air and intestinal secretion collects in the 
intestinal lumen causing abdominal distension and vomiting (or bilious nasogastric 
tube aspirate). Classically there will be a gush of feces and flatus upon digital rectal 
examination. This is due to high pressure in the rectum which was unable to contract 
against anal sphincter. 
After the neonatal period the children would present with chronic constipation, 
especially during the time of weaning for breastfed babies. Most of those presenting 
out of the neonatal period are those with short segment diseases, however even those 
with total colonic involvement may present after the neonatal period. 
Chronic constipation otherwise, in older childhood with accompanying soiling is a 
common and persistent problem in childhood and account for about 3% visits to 
pediatric out-patient clinic and 25% of pediatric gastroenterology clinics. 24 
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Hirschsprung's disease is a rare cause of constipation but need to be considered and 
ruled out as a cause for children of any age with severe constipation. 24 Clinical features 
that indicated invasive investigations of chronic constipation to exclude Hirschsprung's 
disease is by recognition from the history of failure to pass meconium in the first 48 
hours of life, low intermittent intestinal obstruction of unknown cause, severe 
constipation dependant on enemas, chronic abdominal distension and failure to thrive. 
However, many parents do not remember the meconium history. 
2.5. Enterocolitis 
Another clinical presentation that is pertinent to Hirschsprungs disease is enterocolitis. 
The incidence of enterocolitis before the diagnosis of Hirschsprung' s disease is 
established as between 15 and 50%25 • The original description of the entity is credited 
to Bill and Chapman in 1962.3 
This condition is characterized by fever, abdominal distension, diarrhea and 
occasionally vomiting. The condition can be severe and lead to severe dehydration, 
sepsis and death. There is inflammation of the colonic mucosa which can lead to full-
thickness necrosis and eventually perforate causing fecal peritonitis. Stasis and 
bacterial overgrowth caused by functional obstruction of the aganglionic bowel has 
been thought to be etiopathogenic to the condition. 
The pathogenic organtsms include Escherichia Coli. Methicillin Resistant 
Staphylococcus Aureus. Klebsiella pneumonia, Enterococus fecalis and Clostridium 
dificile and other common pathogens 16• Alterations in intestinal mucin production and 
alterations in the mucosal production of immunoglobulins causing loss of intestinal 
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barrier function which allow bacterial translocation are also implicated as etiology of 
enterocolitis associated with Hirschsprung's disease. 26 
The timing of (Hirschsprung's associated enterocolitis) HAEC and the clinical course 
of Hirschsprung' s disease show that the two times an infant has the greatest risk for 
HAEC development are before the diagnosis ofHirschsprung's disease has been made 
and after the definitive surgery. 
Many cases of diarrhea or abdominal distension may be misdiagnosed as 
gastroenteritis or the obstructing sphincter syndrome. 
Table 1: The clinical Grading System for HAEC27 
Grade Clinical Symptoms 
I Mild explosive diarrhea, mild or moderate abdominal distension; 
no systemic manifestations. 
II Moderate explosive diarrhea, moderate to severe abdominal 
distension and mild systemic symptoms. 
III Severe explosive diarrhea, marked abdominal distension and shock 
or impending shock. 
An occasional case of HAEC may present as perforation of the bowel proximal to the 
aganglionic segment. After surgical reconstruction the incidence of enterocolitis is 
between 2% and 33% with a mortality rate varying from 0% to 33%?5 
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There has been a clear decline in the incidence of HAEC over the past 40 years due to 
improved and more prompt diagnosis. The higher risk for HAEC is longer segment 
aganglionosis and trisomy 21 (Down's). 
2.6. Associated congenital anomalies. 
Associated congenital anomalies occur in at least 5-32% of patients and certain 
syndromic phenotypes have been linked to distinct genetic sites, indicating underlying 
genetic associations of the disease and probable gene-gene interaction in its 
pathogenesis. Clear-cut associations with Hirschsprung's disease include Down's 
syndrome, dominant sensorineural deafness, W aardenburg syndrome, 
neurofibromatosis, neuroblastoma, phaeochromocytoma, the MEN type 2B syndrome 
and other abnormalities. Individual anomalies vary from 2.97% to 8%, the most 
frequent being the gastrointestinal tract (GIT) (8.05%), the central nervous system 
(CNS) and sensorineural anomalies (6.79%)and the genito-urinary tract (6.05%). Other 
associated systems include the musculoskeletal (5.12%), cardiovascular systems 
(4.99%), craniofacial and eye abnormalities (3%) and less frequently the skin and 
integumentary system (ectodermal dysplasia) and syndromes related to cholesterol and 
fat metabolism28• 
In addition to associations with neuroblastoma and tumours related to MEN2B, 
Hirschsprung's disease may also be associated with tumors of neural origin such as 
ganglioneuroma, ganglioneuroblastoma, retinoblastoma and tumors associated with 
neurofibromatosis and other autonomic nervous system disturbances28. 
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2. 7. Diagnosis 
Because of the recent advances in perinatal medicine, almost all patients with 
symptoms akin to Hirschsprung's disease are referred to pediatric surgical facility in 
the neonatal period. The investigations are described below. 
2. 7.1. Contrast Enema 
Neonatal plain radiographs cannot differentiate colon from small bowel. In a study 
comparing all the diagnostic methods de Lorijin et al showed that the sensitivity and 
specificity of contrast enema (CE) was 76% and 97% respectiveli9• The presence of a 
caliber change, with a dilated normal colon to a narrowed aganglionic bowel may be 
demonstrated with contrast enema with demarcation of transition zone (Figure 1) 1• 
There was no significant difference between contrast enema appearance in neonates 
compared to infants more than a month old infants (100% vs 90% P=0.27) or in 
children > 1 year old compared with younger children (94% vs 89% respectively 
P=0.21) 29• 
Since only approximately 75% of neonates with Hirschsprung's disease will 
demonstrate a transition zone, absence of a transition zone (a caliber change) does not 
exclude the diagnosis. 3° CE is done by administering barium or water based contrast 
rectally. 
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Figure 1 : The pathognomonic findings of Hirschsprung's disease on 
contrast enema is a transition zone between normal and aganglionic bowel. 
2.7.2. Anorectal Manometry 
Anorectal manometry assesses the rectoanal inhibitory reflex which is absent in 
children with Hirschsprung's disease. Rectoanal inhibitory reflex is absent in the 
majority of children with Hirschsprung's disease thus the use of anorectal manometry 
is helpful in diagnosing Hirschsprung's disease. However, it is unreliable in newborns 
less than 39 weeks of gestation or in those who weigh less than 2700g 29 . The test was 
feasible to be done in older children. Lorijin et al showed a sensitivity rate of 83% and 
specificity rate of 93%29. However technical factors such as air leak in the circuit and 
insufficient inflation of the balloon may cause false positive test results. False negative 
results may be due to the relaxation of external anal sphincter rather than the internal 
anal sphincter. 
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2.7.3. Rectal Biopsy 
Definitive diagnosis is based on histological evaluation of a rectal biopsy, showing the 
presence or absence of ganglion cells and the finding of hypertrophied nerve bundles. 
Swenson advocated full-thickness rectal biopsy first in 1955 to establish diagnosis29• 
Helen Noblett in 1969, introduced a rectal suction biopsy tube which was developed 
specifically for taking rectal biopsies suitable for the diagnosis of Hirschsprung's 
disease.31 
Rectal suction biopsy thence became the most common technique used to sample 
mucosa and the underlying submucosa because of it being non invasive and simple and 
could be done in the ward or in the out patient department. The biopsy is taken at 0.5 to 
1.0 em above the dentate line. The samples were frozen immediately by liquid nitrogen 
and stored at - 80° C. Haematoxylin and Eosin (H & E) staining of the rectal biopsy 
showed absence of ganglion and hypertrophic nerve bundles (Figure 2 and 3). 
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Hypertrophied nerve 
bundles on H & E 
Figure 2: Appearance of Hypertrophied nerve bundles on H & E (Courtesy of Dr 
Shahriman HUSM Pathology Department) 
Ganglion cells on H&E 
(in n01mally innervated 
bowel) 
Figure 3 : Appearance of ganglion in normally innervated bowel on 
H&E (Courtesy of Dr Shahriman HUSM Pathology Department ) 
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Evaluation of suction biopsies may be enhanced by staining for actylcholinestrase, 
which has a characteristic staining pattern in the submucosa and mucosa. 
Acetylcholinesterase staining was done according to the modified Karnofsky and 
Roots method. Martucciello et al accepted rectal suction biopsy as the current gold 
standard in the diagnosis ofHirschsprung's disease 32. 
Positive 
Acetylcholinesterase 
stain 
Figure 4 : The appearance of positive acetylcholinesterase staining. 
(Courtesy of Dr Shahriman HUSM Pathology Department) 
Actylcholinestrase staining of rectal mucosal biopsy in the neonatal period has become 
essential for a definite diagnosis of Hirschsprung's disease (Figure 4). Studies have 
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shown that it is an effective examination with 100% specificity but with slightly low 
sensitivity (91% - 93%). 29•33 Possible false negative results include variability in the 
biopsy site, too superficially taken biopsy material that lacks muscularis mucosa, 
immaturity of the enzyme system, technical variations in performance of the stain and 
the experience of individual pathologists.34 Martucciello et al agreed that European and 
Asian investigators routinely use acetylcholinestrase staining to diagnose 
Hirschsprung' s disease, whereas the American contingent think that H & E is more 
user friendly, cheaper and more reliable to diagnose Hirschsprung's disease32. Thus, 
even though actylcholinestrase staining is an extremely useful for diagnosis only very 
specialized centers can rely on this staining technique for diagnosis32• 
2.8. The extent of aganglionosis 
Rectosigmoid aganglionosis occurs in over 75% of all patients with Hirschsprung's 
disease. 10-15% of cases have long segment disease which extends into the colon 
proximal to the sigmoid and up to right colon. Total colonic aganglionosis is where the 
aganglionosis extends to the whole of the colon and 30 em of the terminal ileum and 
accounts for 3 - 13% of infants with Hirschsprung' s disease. In aganglionosis that 
involves small intestine, the aganglionosis extended orally more that 30cm of the 
terminal ileum. When evaluating Hirschsprung's disease from an etiologic standpoint, 
the long-segment-type cases differ from the short-segment-type cases in regard to the 
sex ratio and the incidence of familial occurrence. 
Ultrashort Hirschsprung's disease (UHD) was enzyme-histochemically characterised 
about 35 years ago. Its existence is still ignored. Reliable diagnosis requires contrast 
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enema to exclude Hirschsprung's disease. It showed no reflux of contrast observed 
during pressing and crying. The final proof of UHD is enzyme-histochemical biopsy 
examination of distal rectal mucosa. The biopsies must be taken from the dentate line 
and 1 ,2,4 and 6 em from the dentate line. Nets of nerve fibres with acetylcholinesterase 
activity can only be found in the muscularis mucosae and musculus corrugator cutis ani 
(MCCA). Its incidence is about 13.4%.35 
2.8.1. Total colonic aganglionosis 
Total colonic aganglionosis (TCA) accounts for approximately 3% to 12% of infants 
with Hirschsprung's disease and is associated with increased morbidity and mortality29• 
Total colonic aganglionosis can be very difficult to diagnose. Radiographic studies 
may show dilated loops of intestine, and an enema contrast study may show a question-
mark-shaped colon, which results from the rounded edges of the splenic and hepatic 
flexures of an unused colon (Figure 5) 1• 
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Figure 5 : The appearance of Barium enema of total colonic aganglionosis 
showing presence of microcolon appearance till the caecum 1• 
The diagnosis is generally made at the time of laparotomy for suspected intestinal 
obstruction or perforation or while a leveling colostomy for Hirschsprung's disease is 
being done. A frozen section of an aganglionic appendix is almost always diagnostic. 
Total colonic aganglionosis has higher association with family history ranging from 
12.4 to 33%. 11 The male to- female ratio is also less at 1.3:1. 11 Bickler et al found 
the proximal extent of aganglionosis was the terminal ileum in 76%, mid ileum in 
19%, and the jej Lmum in 5%.36 
Treatment begins with the creation of a properly placed enterostomy. Nutrition is 
usually ini tiated parenterally and slowly converted to the enteral route. Failure to thrive 
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